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Mohs skin cancer surgery is also known as microscopically-controlled 
surgery because at each stage in the Mohs procedure, a new layer of tissue is 
obtained surgically and frozen sections made, allowing a microscopic reading of 
the tissue margins.  The Mohs technique, sometimes requiring 3 or more hours 
because of the pathology determinations, is repeated until the final surgical 
margins are clear, allowing an overall cure rate exceeding ~97%.   Mohs surgery, 
although more costly than traditional excisional surgery or simple curettage, is 
often advocated for patients because of the high rate of cure and because it is 
said to be tissue sparing, requiring no wider margins than the minimal margins 
needed for tumor clearance.  A novel optical technique which would allow skin 
cancer margin determination is an important goal of the dermatology image 
research community, because such a technique would eliminate the lengthy and 
expensive intervening pathology steps, greatly reducing clinic time spent on the 
procedure, yielding a similar cure rate at a much lower cost.  
An Italian research group has reported a cure rate for excisional surgery 
exceeding 98%. Using a tissue optic phenomenon in dermoscopy called 
“semitranslucency.”  Dermoscopic semistranslucency, first described by 
researchers at S&A and colleagues, has been used in one clinic to determine 
successful extirpation using curettage.  We have confirmed that 
semitranslucency yields good indication of whether any skin cancer remains.  
This report describes the use of semitranslucency and the distinction of 
semitranslucency from two competing structures:  white chrysalis structures and 
sparkling orange structures, visible with cross-polarized light.  Plans to further 
optimize the cross-polarized light source are presented  
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